Healthcare & Life Sciences
Pliant Therapeutics
series-b
series-b
Stage
1
Investors
About
Pliant Therapeutics develops therapies for a range of fibrotic diseases by focusing on fibrotic tissue–specific inhibition of integrins. The company is a clinical-stage, publicly listed biotech targeting fibrotic indications.
Explore Pliant Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.